CME Session
Hybrid Session
Pavlos Msaouel, MD, PhD
University of Texas MD Anderson Cancer CenterHouston, Texas, United States
Disclosure: Disclosure(s): Non-CE Consulting: Mirati Therapeutics (Terminated, June 7, 2021)